Abstract
Purpose
Advanced glycation end products (AGEs) formed in food during high-heat cooking may induce overeating and inflammation. We investigated whether AGE contents in a single meal affect postprandial appetite and markers of inflammation, endothelial activation, and oxidative stress.
Methods
In total, 19 healthy overweight individuals completed a crossover meal test with two meals of identical ingredients prepared by roasting (H-AGE) or steaming (L-AGE), respectively. Postprandial blood samples were analysed for Nε-carboxymethyl-lysine (CML), appetite-regulating gut hormones, glucose, insulin, triacylglycerol, and markers of inflammation and endothelial activation. Subjective appetite ratings and subsequent food intake were also assessed, and urine was analysed for CML, methylglyoxal-derived hydroimidazolone (MG-H1), and F2-isoprostanes.
Results
CML content of the H- and L-AGE meals was 5.0 and 2.8 mg, respectively. Plasma CML and urinary CML and MG-H1 tended to be higher after the H-AGE meal. There was no change in subsequent food intake, appetite sensations, or appetite hormone responses between meals, except for the overall ghrelin response, which was higher after the H-AGE meal compared with the L-AGE meal (p = 0.016). There was an increased glycaemic response to the H-AGE meal (p = 0.027) compared with the L-AGE meal. Inflammatory and endothelial activation markers did not differ between meals, but there was an overall effect on endothelial activation (p = 0.021) and on the oxidative marker, F2-isoprostanes, in urine (p = 0.013).
Conclusion
The present study did not show any pronounced effects of AGEs on appetite and markers of inflammation, but did indicate that AGEs may affect postprandial ghrelin, oxidative stress, and glucose responses.
Similar content being viewed by others
Abbreviations
- AGE:
-
Advanced glycation end product
- AUC:
-
Area under curve
- CML:
-
Nε-carboxymethyl-lysine
- CRP:
-
C-reactive protein
- GLP-1:
-
Glucagon-like peptide-1
- H-AGE:
-
High-advanced glycation end products
- ICAM-1:
-
Intercellular adhesion molecule-1
- IL-6:
-
Interleukin-6
- L-AGE:
-
Low-advanced glycation end product
- MG-H1:
-
Methylglyoxal-derived hydroimidazolone
- PABA:
-
Para-aminobenzoic acid
- PYY:
-
Peptide YY
- RAGE:
-
Receptor for advanced glycation end product
- TNF-α:
-
Tumour necrosis factor-α
- VAS:
-
Visual analogue scale
- VCAM-1:
-
Vascular cell adhesion molecule-1
- isoPGF2α :
-
F2-isoprostaglandins
References
Hossain P, Kawar B, El NM (2007) Obesity and diabetes in the developing world—a growing challenge. N Engl J Med 356:213–215
Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H (2010) Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 110:911–916
van Boekel MA (2006) Formation of flavour compounds in the Maillard reaction. Biotechnol Adv 24:230–233
Perez-Locas C, Yaylayan VA (2010) The Maillard reaction and food quality deterioration. In: Skibsted LH, Risbo J, Andersen ML (eds) Chemical deterioration and physical instability of food and beverages. Woodhead Publishing, Cambridge, pp 70–94
Vlassara H, Striker GE (2011) AGE restriction in diabetes mellitus: a paradigm shift. Nat Rev Endocrinol 7:526–539
Cai W, Gao QD, Zhu L, Peppa M, He C, Vlassara H (2002) Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med 8:337–346
Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF (1999) Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 22:1543–1548
Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS (2002) Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 25:1055–1059
Tan KC, Chow WS, Tam S, Bucala R, Betteridge J (2004) Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care 27:223–228
Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Gotting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D (2007) Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 85:1236–1243
Flint A, Raben A, Blundell JE, Astrup A (2000) Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 24:38–48
Bingham S, Cummings JH (1983) The use of 4-aminobenzoic acid as a marker to validate the completeness of 24 h urine collections in man. Clin Sci 64:629–635
Orskov C, Jeppesen J, Madsbad S, Holst JJ (1991) Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest 87:415–423
Zhang H, Il’yasova D, Sztaray J, Young SP, Wang F, Millington DS (2010) Quantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Anal Biochem 399:302–304
Ames JM (2008) Determination of N epsilon-(carboxymethyl)lysine in foods and related systems. Ann N Y Acad Sci 1126:20–24
Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375:581–592
Jongberg S, Rasmussen M, Skibsted LH, Olsen K (2012) Detection of advanced glycation end-products (AGEs) during dry-state storage of beta-lactoglobulin/lactose. Aust J Chem 65:1620–1624
Birlouez-Aragon I, Saavedra G, Tessier FJ, Galinier A, Ait-Ameur L, Lacoste F, Niamba CN, Alt N, Somoza V, Lecerf JM (2010) A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr 91:1220–1226
Delgado-Andrade C, Tessier FJ, Niquet-Leridon C, Seiquer I, Pilar NM (2012) Study of the urinary and faecal excretion of Nepsilon-carboxymethyllysine in young human volunteers. Amino Acids 43:595–602
Schiekofer S, Franke S, Andrassy M, Chen J, Rudofsky G, Schneider JG, von EM, Wendt T, Morcos M, Kientsch-Engel R, Stein G, Schleicher E, Nawroth PP, Bierhaus A (2006) Postprandial mononuclear NF-kappaB activation is independent of the AGE-content of a single meal. Exp Clin Endocrinol Diabetes 114:160–167
Janssen P, Van den Berghe P, Verschueren S, Lehmann A, Depoortere I, Tack J (2011) Review article: the role of gastric motility in the control of food intake. Aliment Pharmacol Ther 33:880–894
Koschinsky T, He CJ, Mitsuhashi T, Bucala R, Liu C, Buenting C, Heitmann K, Vlassara H (1997) Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 94:6474–6479
Henle T (2007) Dietary advanced glycation end products—a risk to human health? A call for an interdisciplinary debate. Mol Nutr Food Res 51:1075–1078
Henle T (2008) Maillard reaction of proteins and advanced glycation end products (AGEs) in food. In: Stadler RH, Lineback DR (eds) Process-induced food toxicants. Wiley, Hoboken, pp 215–242
Assar SH, Moloney C, Lima M, Magee R, Ames JM (2009) Determination of Nepsilon-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry. Amino Acids 36:317–326
Sebekova K, Klenovics KS, Boor P, Celec P, Behuliak M, Schieberle P, Heidland A, Palkovits M, Somoza V (2012) Behaviour and hormonal status in healthy rats on a diet rich in Maillard reaction products with or without solvent extractable aroma compounds. Physiol Behav 105:693–701
Ruijschop RM, Boelrijk AE, de Ru JA, de Graaf C, Westerterp-Plantenga MS (2008) Effects of retro-nasal aroma release on satiation. Br J Nutr 99:1140–1148
Ruijschop RM, Boelrijk AE, Burgering MJ, de Graaf C, Westerterp-Plantenga MS (2010) Acute effects of complexity in aroma composition on satiation and food intake. Chem Senses 35:91–100
Gil-Campos M, Aguilera CM, Canete R, Gil A (2006) Ghrelin: a hormone regulating food intake and energy homeostasis. Br J Nutr 96:201–226
Stirban A, Negrean M, Gotting C, Stratmann B, Gawlowski T, Mueller-Roesel M, Kleesiek K, Koschinsky T, Tschoepe D (2008) Leptin decreases postprandially in people with type 2 diabetes, an effect reduced by the cooking method. Horm Metab Res 40:896–900
Rosen LA, Ostman EM, Bjorck IM (2011) Effects of cereal breakfasts on postprandial glucose, appetite regulation and voluntary energy intake at a subsequent standardized lunch; focusing on rye products. Nutr J 10:7
Miele C, Riboulet A, Maitan MA, Oriente F, Romano C, Formisano P, Giudicelli J, Beguinot F, Van OE (2003) Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism. J Biol Chem 278:47376–47387
Unoki H, Bujo H, Yamagishi S, Takeuchi M, Imaizumi T, Saito Y (2007) Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res Clin Pract 76:236–244
Cassese A, Esposito I, Fiory F, Barbagallo AP, Paturzo F, Mirra P, Ulianich L, Giacco F, Iadicicco C, Lombardi A, Oriente F, Van OE, Beguinot F, Formisano P, Miele C (2008) In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. J Biol Chem 283:36088–36099
Puddu A, Storace D, Odetti P, Viviani GL (2010) Advanced glycation end-products affect transcription factors regulating insulin gene expression. Biochem Biophys Res Commun 395:122–125
Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, Zhu L, Striker GE, Vlassara H (2011) Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 34:1610–1616
Uribarri J, Stirban A, Sander D, Cai W, Negrean M, Buenting CE, Koschinsky T, Vlassara H (2007) Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care 30:2579–2582
Aljada A, Mohanty P, Ghanim H, Abdo T, Tripathy D, Chaudhuri A, Dandona P (2004) Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr 79:682–690
Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ (2002) Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 99:15596–15601
Peppa M, Uribarri J, Cai W, Lu M, Vlassara H (2004) Glycoxidation and inflammation in renal failure patients. Am J Kidney Dis 43:690–695
Vlassara H, Cai WJ, Goodman S, Pyzik R, Yong A, Chen X, Zhu L, Neade T, Beeri M, Silverman JM, Ferrucci L, Tansman L, Striker GE, Uribarri J (2009) Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab 94:4483–4491
Vlassara H, Fuh H, Donnelly T, Cybulsky M (1995) Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1:447–456
Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395–1403
Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De CR (2002) Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105:816–822
Basta G, Lazzerini G, Del TS, Ratto GM, Schmidt AM, De CR (2005) At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol 25:1401–1407
Ramasamy R, Yan SF, Herold K, Clynes R, Schmidt AM (2008) Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acad Sci 1126:7–13
Ramasamy R, Yan SF, Schmidt AM (2011) Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci 1243:88–102
Coelho RC, Hermsdorff HH, Bressan J (2013) Anti-inflammatory properties of orange juice: possible favorable molecular and metabolic effects. Plant Foods Hum Nutr 68:1–10
Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, Wolever TM (2005) Glycaemic index methodology. Nutr Res Rev 18:145–171
Acknowledgments
The authors would like to thank Pia Lisbeth Madsen, Hanne Lysdal Petersen, Sarah Fleischer Ben Soltane, Charlotte Kostecki, and Yvonne Fatum for their excellent technical assistance, students Anne-Ditte Termannsen and Pia Øllgaard Olsen for their assistance with data collection, and the volunteers who participated in the study. The work was carried out as part of the research programme of the UNIK: Food, Fitness & Pharma for Health and Disease (see www.footfitnesspharma.ku.dk). The UNIK project is supported by the Danish Ministry of Science, Technology and Innovation. Additional samples for collaboration are stored in the open biobank CUBE (www.cube.ku.dk). The authors declare no conflicts of interest. MWP, LL, SB, and LOD designed the study. MWP and ACG-F conducted the study. MJB and JJH carried out the analyses of gut hormones. JMA and JN synthesised standards for the AGE analysis. JMA carried out the analysis of AGEs. RM carried out the analysis of isoprostanes. MWP performed the statistical analyses and wrote the manuscript. LHL, LL, SB, and LOD provided significant scientific advice on the interpretation of the data. All authors revised and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
The study was registered at www.clinicaltrials.gov with identifier NCT01434407.
Rights and permissions
About this article
Cite this article
Poulsen, M.W., Bak, M.J., Andersen, J.M. et al. Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals. Eur J Nutr 53, 661–672 (2014). https://doi.org/10.1007/s00394-013-0574-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-013-0574-y